218 related articles for article (PubMed ID: 7495557)
1. In situ assessment of beta-hexosaminidase activity.
Lacorazza HD; Jendoubi M
Biotechniques; 1995 Sep; 19(3):434-40. PubMed ID: 7495557
[TBL] [Abstract][Full Text] [Related]
2. Isoenzymes of N-acetyl-beta-hexosaminidase.
Zwierz K; Zalewska A; Zoch-Zwierz A
Acta Biochim Pol; 1999; 46(3):739-51. PubMed ID: 10698282
[TBL] [Abstract][Full Text] [Related]
3. Rapid detection of fetal Mendelian disorders: Tay-Sachs disease.
Guetta E; Peleg L
Methods Mol Biol; 2008; 444():147-59. PubMed ID: 18425478
[TBL] [Abstract][Full Text] [Related]
4. [Beta-N-acetyl-hexosaminidase--the enzyme of Tay-Sachs and Sandhoff diseases].
Zwierz K; Juszkiewicz J; Arciuch L; Gindzieński A
Postepy Biochem; 1992; 38(3):127-32. PubMed ID: 1461844
[No Abstract] [Full Text] [Related]
5. Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer.
Akli S; Guidotti JE; Vigne E; Perricaudet M; Sandhoff K; Kahn A; Poenaru L
Gene Ther; 1996 Sep; 3(9):769-74. PubMed ID: 8875224
[TBL] [Abstract][Full Text] [Related]
6. beta-hexosaminidase in cultured normal and mutant human fibroblasts: an immunohistochemical and biochemical investigation.
Elsafi ME; Elbashir MI; Hultberg B; Isaksson A; Hägerstrand I; Stenram U
Scand J Clin Lab Invest; 1991 Dec; 51(8):711-4. PubMed ID: 1839650
[TBL] [Abstract][Full Text] [Related]
7. Unusual thermolability properties of beta-hexosaminidase: studies of enzyme from cultured cells and clinical implications.
Prence EM; Zalewski I; Natowicz MR
Am J Med Genet; 1996 Nov; 65(4):320-4. PubMed ID: 8923943
[TBL] [Abstract][Full Text] [Related]
8. Identification of an active acidic residue in the catalytic site of beta-hexosaminidase.
Tse R; Vavougios G; Hou Y; Mahuran DJ
Biochemistry; 1996 Jun; 35(23):7599-607. PubMed ID: 8652542
[TBL] [Abstract][Full Text] [Related]
9. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
Bayleran J; Hechtman P; Kolodny E; Kaback M
Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease.
Mark BL; Mahuran DJ; Cherney MM; Zhao D; Knapp S; James MN
J Mol Biol; 2003 Apr; 327(5):1093-109. PubMed ID: 12662933
[TBL] [Abstract][Full Text] [Related]
11. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of enantiomeric beta-N-acetylhexosaminidase inhibitors LABNAc and DABNAc as potential agents against Tay-Sachs and Sandhoff disease.
Rountree JS; Butters TD; Wormald MR; Boomkamp SD; Dwek RA; Asano N; Ikeda K; Evinson EL; Nash RJ; Fleet GW
ChemMedChem; 2009 Mar; 4(3):378-92. PubMed ID: 19145603
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.
Tropak MB; Reid SP; Guiral M; Withers SG; Mahuran D
J Biol Chem; 2004 Apr; 279(14):13478-87. PubMed ID: 14724290
[TBL] [Abstract][Full Text] [Related]
14. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
15. II. Characterization and development of the regional- and cellular-specific abnormalities in the epididymis of mice with beta-hexosaminidase A deficiency.
Adamali HI; Somani IH; Huang JQ; Gravel RA; Trasler JM; Hermo L
J Androl; 1999; 20(6):803-24. PubMed ID: 10591619
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
Inui K; Wenger DA
Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
[TBL] [Abstract][Full Text] [Related]
17. Structure and distribution of an Alu-type deletion mutation in Sandhoff disease.
Neote K; McInnes B; Mahuran DJ; Gravel RA
J Clin Invest; 1990 Nov; 86(5):1524-31. PubMed ID: 2147027
[TBL] [Abstract][Full Text] [Related]
18. Tay-Sachs disease-causing mutations and neutral polymorphisms in the Hex A gene.
Myerowitz R
Hum Mutat; 1997; 9(3):195-208. PubMed ID: 9090523
[TBL] [Abstract][Full Text] [Related]
19. beta-hexosaminidase lentiviral vectors: transfer into the CNS via systemic administration.
Kyrkanides S; Miller JH; Brouxhon SM; Olschowka JA; Federoff HJ
Brain Res Mol Brain Res; 2005 Feb; 133(2):286-98. PubMed ID: 15710246
[TBL] [Abstract][Full Text] [Related]
20. Cultured skin fibroblasts in lipidoses. Enzymatic, histochemical, and ultrastructural relationship in Fabry's Tay-Sachs, and Sandhoff's diseases.
Yuasa T; Fukuma M; Takashima S; Takaki R
Arch Pathol Lab Med; 1980 Jun; 104(6):321-7. PubMed ID: 6246846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
